Neurocrine Biosciences (NBIX) Goodwill (2022 - 2024)

Neurocrine Biosciences' Goodwill history runs 3 years deep, the most recent figure standing at $5.7 million for Q4 2024.

• Quarterly Goodwill fell 1.72% year-over-year to $5.7 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $5.7 million (down 1.72% YoY) and the FY2024 annual result came in at $5.7 million, down 1.72% from the prior year.
• Goodwill was $5.7 million for Q4 2024 at Neurocrine Biosciences, down from $6.1 million in the prior quarter.
• Across five years, Goodwill topped out at $6.1 million in Q3 2024 and bottomed at $5.4 million in Q4 2022.
• A 3-year average of $5.7 million and a median of $5.7 million in 2023 frame the typical range for Goodwill.
• Peak annual rise in Goodwill reached 10.91% in 2024, while the deepest fall reached 1.72% in 2024.
• Neurocrine Biosciences' Goodwill stood at $5.4 million in 2022, then advanced by 7.41% to $5.8 million in 2023, then retreated by 1.72% to $5.7 million in 2024.
• Business Quant data shows NBIX's Goodwill at $5.7 million in Q4 2024, $6.1 million in Q3 2024, and $5.7 million in Q2 2024.